Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

Summary

This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled, parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute uncomplicated ILI due to influenza or other respiratory viruses in a community setting.

Timeline

Start

2019-10-21

Primary completion

2020-04-05

Completion

2020-04-20

Drugs

Indications